Precipio, Inc. — Director's Dealing 2015

Apr 3, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TRANSGENOMIC INC (TBIO)
CIK: 0001043961
Period of Report: 2015-04-01

Reporting Person: Kinnon Paul (Director, CEO, President and Interim CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-04-01	Stock Option (Right to Buy)	$1.44	A	75000	Acquired	2025-04-01	Common Stock (75000)	Direct

Footnotes

F1: The option was granted on 4/1/2015 and is exercisable as it vests. The option vests over a three year period, with 1/3 of the shares subject to the option vesting on each one year anniversary of the date of grant, subject to the reporting person's continued employment with (or providing continuous service to) the issuer on each such date.